LABZ — Metasphere Labs Balance Sheet
0.000.00%
- CA$1.63m
- CA$1.49m
- CA$2.20m
Annual balance sheet for Metasphere Labs, fiscal year end - July 31st, CAD millions except per share, conversion factor applied.
2020 July 31st | 2021 July 31st | R2022 July 31st | 2023 July 31st | 2024 July 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.015 | 0.002 | 0.308 | 0.047 | 0.9 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | — | — | 0.215 | 0.111 | 0.101 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 0.015 | 0.002 | 0.985 | 0.253 | 1.02 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | — | — | 0.457 | 0.262 | 0 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 0.015 | 0.002 | 7.46 | 0.837 | 1.02 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.109 | 0.15 | 1.13 | 2.7 | 1.35 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.109 | 0.15 | 3.97 | 4.94 | 1.35 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -0.095 | -0.147 | 3.49 | -4.1 | -0.336 |
| Total Liabilities & Shareholders' Equity | 0.015 | 0.002 | 7.46 | 0.837 | 1.02 |
| Total Common Shares Outstanding |